About Endpoints News
Endpoints News (a Financial Times company) has played a central role covering every major development in the biopharmaceutical industry on a daily basis for the past 7 years. One of the hottest growing brands in new media, we are growing fast. Endpoints is here to inform and connect players in the biopharma world as they work to deliver on that promise. Your work here directly contributes to that mission every day.